SCHEMBL828709

SCHEMBL828709

O=C(Cl)OC[C@@H](COCc1ccccc1)OCc1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.57
SLC1A1 P43005 3/20 0.44
CA1 P00915 4/20 0.44
CA2 P00918 2/20 0.44
CA7 P43166 2/20 0.44
CA9 Q16790 2/20 0.44
SLC1A3 P43003 2/20 0.42
SLC1A2 P43004 2/20 0.42
KMT2A Q03164 2/20 0.42
TBXAS1 P24557 1/20 0.42
MEN1 O00255 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
TSHR P16473 1/20 0.41
MAPK1 P28482 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
FOLH1 Q04609 1/20 0.40
SLC6A2 P23975 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL828710 1.00 ALDH1A1 (0.57) ALDH1A1SLC1A1CA1CA2CA7
SCHEMBL828711 1.00 ALDH1A1 (0.57) ALDH1A1SLC1A1CA1CA2CA7
SCHEMBL4535813 0.84 TDP1 (0.58) ALDH1A1SLC1A1CA1CA2CA7
SCHEMBL4535810 0.83 TSHR (0.58) SLC1A1CA1CA2CA7CA9
SCHEMBL6139421 0.83 SLC1A1 (0.48) SLC1A1CA1CA2CA7CA9
SCHEMBL1492511 0.80 SLC1A3 (0.49) ALDH1A1SLC1A1CA1CA2CA9
SCHEMBL28610357 0.80 ALDH1A1 (0.46) ALDH1A1SLC1A1CA1CA2CA7
SCHEMBL9197596 0.79 ALDH1A1 (0.54) ALDH1A1SLC1A1CA1CA2CA7
SCHEMBL9814040 0.79 HTT (0.47) ALDH1A1SLC1A1CA1CA2CA7
SCHEMBL9845277 0.79 TSHR (0.48) SLC1A1CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1724262-B1 1-(2H)-ISOQUINOLONE DERIVATIVE CHUGAI PHARMACEUTICAL CO LTD (JP) 2012-05-02 EP disclosed
US-8143274-B2 1-(2H)-isoquinolone derivative CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2012-03-27 US disclosed
US-20070185160-A1 1-(2H)-isoquinolone derivative CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2007-08-09 US disclosed
EP-1724262-A1 1-(2H)-ISOQUINOLONE DERIVATIVE CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2006-11-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070185160-A1 1-(2H)-isoquinolone derivative NR3C2, NR1H4, NR3C1 ALDH1A1 2752/4885SLC1A1 771/4885CA1 2667/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.